NovoCure LimitedNVCRNASDAQ

Revenue (LTM)

$655M

+8.3% YoY

Net Income (LTM)

$-136M

+19.2% YoY

Free Cash Flow

$-76M

Revenue CAGR (5Y)

+5.8%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	535	538↑0.5%	509↓5.3%	605↑18.8%	655↑8.3%
Gross Profit	420	423↑0.7%	381↓9.9%	468↑22.8%	488↑4.4%
Operating Income	-44	-90↓101.9%	-233↓160.1%	-170↑26.8%	-154↑9.8%
Net Income	-58	-93↓58.6%	-207↓123.7%	-169↑18.6%	-136↑19.2%
EBITDA	-38	-68↓76.9%	-177↓161.4%	-110↑38.2%	-119↓8.6%
EPS Diluted	-0.56	-0.88↓57.1%	-1.95↓121.6%	-1.56↑20.0%	-1.22↑21.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	210	115↓45.0%	241↑108.8%	164↓32.0%	103↓36.9%
Total Current Assets	1,074	1,112↑3.5%	1,034↓6.9%	1,107↑7.0%	647↓41.6%
Total Assets	1,139	1,192↑4.6%	1,146↓3.8%	1,241↑8.3%	804↓35.2%
Total Current Liabilities	143	159↑11.3%	179↑12.8%	756↑322.3%	223↓70.5%
Total Liabilities	729	750↑2.9%	784↑4.4%	881↑12.4%	464↓47.3%
Total Equity	410	441↑7.5%	362↓17.8%	360↓0.6%	340↓5.5%
Total Debt	582	584↑0.4%	596↑2.0%	683↑14.6%	290↓57.6%
Net Debt	372	469↑26.0%	355↓24.2%	520↑46.2%	187↓64.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	83	31↓62.8%	-73↓338.2%	-26↑64.0%	-49↓85.9%
Capital Expenditure	-24	-21↑11.6%	-27↓26.9%	-43↓58.2%	-27↑37.8%
Free Cash Flow	59	9↓83.9%	-100↓1165.0%	-69↑31.1%	-76↓9.3%
Stock-Based Comp	95	107↑12.7%	116↑8.1%	160↑38.4%	0
Net Change in Cash	-37	-94↓156.5%	127↑235.1%	-76↓160.3%	-63↑18.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance